BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31749286)

  • 21. Solid tumors.
    Richardson RC
    Vet Clin North Am Small Anim Pract; 1985 May; 15(3):557-67. PubMed ID: 3892869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soft tissue sarcomas.
    Mauldin GN
    Vet Clin North Am Small Anim Pract; 1997 Jan; 27(1):139-48. PubMed ID: 9002173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
    Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
    Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
    Baker-Gabb M; Hunt GB; France MP
    Aust Vet J; 2003 Dec; 81(12):732-8. PubMed ID: 15080482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas.
    Spugnini EP; Vincenzi B; Citro G; Santini D; Dotsinsky I; Mudrov N; Montesarchio V; Laieta MT; Esposito V; Baldi A
    In Vivo; 2007; 21(5):819-22. PubMed ID: 18019417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
    Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative radiotherapy for canine soft tissue sarcoma.
    Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
    J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major developments in the understanding and treatment of soft-tissue sarcomas in adults.
    Demetri GD
    Curr Opin Oncol; 1998 Jul; 10(4):343-7. PubMed ID: 9702402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
    McSporran KD
    Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005-2012).
    Prpich CY; Santamaria AC; Simcock JO; Wong HK; Nimmo JS; Kuntz CA
    J Am Vet Med Assoc; 2014 Jan; 244(2):187-94. PubMed ID: 24378028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
    Bergman NS; Urie BK; Pardo AD; Newman RG
    J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
    Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; LiƩnard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ
    Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
    Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
    J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases.
    Chase D; Bray J; Ide A; Polton G
    J Small Anim Pract; 2009 Nov; 50(11):568-74. PubMed ID: 19814769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role of immunotherapy for the treatment of sarcoma.
    Klemen ND; Kelly CM; Bartlett EK
    J Surg Oncol; 2021 Mar; 123(3):730-738. PubMed ID: 33259653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soft tissue sarcoma in the dog - part 1: a current review.
    Bray JP
    J Small Anim Pract; 2016 Oct; 57(10):510-519. PubMed ID: 27624929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma.
    Kung MBJ; Poirier VJ; Dennis MM; Vail DM; Straw RC
    Vet Comp Oncol; 2016 Dec; 14(4):e135-e145. PubMed ID: 25393921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metronomic chemotherapy.
    Mutsaers AJ
    Top Companion Anim Med; 2009 Aug; 24(3):137-43. PubMed ID: 19732732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials.
    Tang F; Tie Y; Wei YQ; Tu CQ; Wei XW
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188606. PubMed ID: 34371128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.